India markets closed
  • BSE SENSEX

    49,099.99
    -1,939.32 (-3.80%)
     
  • Nifty 50

    14,529.15
    -568.20 (-3.76%)
     
  • USD/INR

    73.9170
    +1.1760 (+1.62%)
     
  • Dow

    30,932.37
    -469.64 (-1.50%)
     
  • Nasdaq

    13,192.35
    +72.92 (+0.56%)
     
  • BTC-INR

    3,393,766.00
    +4,198.25 (+0.12%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • Hang Seng

    28,980.21
    -1,093.96 (-3.64%)
     
  • Nikkei

    28,966.01
    -1,202.26 (-3.99%)
     
  • EUR/INR

    89.6708
    +1.0140 (+1.14%)
     
  • GBP/INR

    103.2008
    +1.2652 (+1.24%)
     
  • AED/INR

    20.0800
    +0.3210 (+1.62%)
     
  • INR/JPY

    1.4390
    -0.0183 (-1.26%)
     
  • SGD/INR

    55.5940
    +0.6850 (+1.25%)
     

Michael J. Hennessy Jr., President and CEO of MJH Life Sciences™, Named One of MM+M’s 2021 40 Under 40 Honorees

·4-min read

The prestigious recognition shines a spotlight on the industry’s sharpest, most creative young talent working in medical marketing.

MJH Life Sciences™ is excited to announce that Michael J. Hennessy Jr., the company’s president and chief executive officer (CEO), has been recognized by MM+M as one of the most influential leaders under the age of 40 in the pharma and health care marketing sectors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210223005786/en/

(Photo: Business Wire)

MM+M’s 40 Under 40 list features 40 inspiring leaders who have shown great promise, talent and creativity in the pharma and health care marketing industries from the onset of their careers. Hennessy joins a class of inductees from across the industry ranging from pharma, biotech companies and agencies to device manufacturers, analytics firms and health media.

Hennessy began his career as a national account manager at MJH Associates in 2010 and by September 2015 was elevated to president of the company. As president, Hennessy was responsible for identifying new business opportunities and driving the overall growth of the organization. In 2019, Michael was promoted to president and CEO of MJH Life Sciences™.

Since the beginning of his career, Hennessy has demonstrated his vision for creating new, engaging ways to serve health care professionals. After overseeing sustained, organic growth, Hennessy elevated MJH even further by acquiring UBM Life Sciences Group in January 2019. The acquisition came with 7 offices and over 220 associates. Hennessy has since led the integration of the UBM assets, streamlining the company and reinvigorating the acquired brands to deliver on MJH’s vision of helping health care professionals improve patient care.

Hennessy’s visionary leadership was further demonstrated by how he led the company during the COVID-19 pandemic. Hennessy leveraged his state-of-the-art MJH Studios to quickly pivot the company’s events to virtual without missing a beat. In addition to hosting even more events than before, Hennessy continued to innovate and launch new offerings. In June, MJH launched Medical World News®, a first-of-its-kind news channel for health care professionals. He then launched the MJH Life Sciences™ COVID-19 Coalition, a partnership with health care thought leaders devoted to providing ongoing insight around the pandemic and patient care. MJH has grown under Hennessy’s leadership to 60 brands, producing over 975 events and reaching 7.3 million unique visitors per month online and 2 million via print.

"2020 was a year unlike any other, but I am so proud of our team and the success we had in the marketplace," Hennessy said. "In 2021, I look forward to investing in additional areas of growth within the business while simultaneously continuing our position as thought leaders in the industry. It is a true honor to build upon the legacy my father, Mike Hennessy Sr., has established here at MJH Life Sciences™."

The 2021 honorees will be celebrated during a virtual awards ceremony on Thursday, March 25.

For more information on MM&M’s 40 Under 40 list and recipients, click here.

About MJH Life Sciences™

MJH Life Sciences is the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit https://www.mjhlifesciences.com/.

About MM+M

First published in 1966 as Medical Marketing & Media, MM+M is the media brand of record for pharmaceutical marketing and commercialization, delivering the most balanced and relevant coverage of the growing industry. The title produces an essential mix of online breaking news and analysis combined with monthly print features — timely, objective, original editorial content for an executive audience of leaders and thinkers who work in pharma, medical device, diagnostics and greater healthcare marketing. MM+M also develops conferences and live and virtual events, and engineers the industry’s premier awards program, the MM+M Awards.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210223005786/en/

Contacts

MJH Life Sciences™ Media Contact
Alexandra Ventura, 609-716-7777
aventura@mjhlifesciences.com